pharmaphorum

JANUARY 5, 2021

TIGIT is very much among the front runners however, and Roche is being closely pursued by other drug developers including Merck & Co with MK-7684 and Gilead/Arcus, which are also in mid-stage testing, as well as iTeos Therapeutics and Mereo BioPharma.

Immune Response 52

Immune Response FDA Approval Drugs Sales 52

XTalks

AUGUST 17, 2020

To learn more about innovations in the field, Xtalks spoke to Anish Suri, PhD, president and chief scientific officer of Cue Biopharma about the company’s initiatives in the development of immune-based biological compounds for the treatment of cancers and autoimmune diseases. Image from Cue Biopharma.

Protein 98

Protein Engineer Immune Response In-Vivo 98

pharmaphorum

JUNE 15, 2021

The pandemic’s disruption galvanised the biopharma industry into unprecedented action, demonstrating what’s possible when the global scientific community collaborates in exceptional ways and public-private partnerships drive innovation to address a common need. These will all help pay for New Science. .

Clinical Trials 89

Clinical Trials Clinical Trials Development Marketing 89

XTalks

AUGUST 19, 2022

Zynteglo’s hefty price tag of $2.8 What’s happening to them is not unique to bluebird,” said Nicole Paulk, an assistant professor of AAV gene therapy at the University of California, San Francisco in a Biopharma Dive report. The cells are prepared outside of the body ( ex vivo ) and then infused into the patient.

Gene Therapy 95

Gene Therapy FDA Approval Gene Clinical Trials 95

Drug Discovery World

NOVEMBER 13, 2023

Respectively, they will be moderated by Karoline Bechtold-Peters, PhD, Senior Strategy & Technology Leader, Pharmaceuticals & Biopharma Process, Novartis Pharma, and Bernhard Valldorf, PhD, Targeting Director, Targeted mRNA Delivery, EMD Serono.

Protein 59

Protein Antibody Engineer Scientist 59

XTalks

MARCH 22, 2023

The years that followed have seen a rise in large pharma companies acquiring much smaller biopharmas with a narrow focus on rare disease therapeutic development. In addition, nearly half of all new drugs launched between 2020 and 2021 came with a price tag of $150,000 per year, or more.

Life Science 97

Life Science Drugs FDA Approval Vaccination 97

Drug Discovery World

NOVEMBER 9, 2023

Ioanna Stamati, PhD, Team Leader, Bioconjugation, Antikor Biopharma, on: ‘Antibody fragment drug-conjugates (FDCs): Analysing novel formats with high DAR’. The presentations include: Laura Sewell, Scientist, Biopharmaceutical Development, AstraZeneca, on: ‘Challenges of working with a two-faced bispecific — one size does not fit all’.

Engineer 52

Engineer Antibody Protein In-Vivo 52

The Pharma Data

MAY 5, 2021

. Esker, a new biotech startup, launches with plans to make targeted immune drugs ( BioPharma Dive ). AbbVie’s Humira regains top pharma TV spender spot, while sibling brands Rinvoq and Skyrizi tag along ( Fierce ). Pfizer ups COVID-19 vaccine revenue estimates ( BioPharma Reporter ).

Vaccination 52

Vaccination Vaccine Gene Therapy Contract Packaging 52